SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Drugs soars on bagging orders worth Rs 14.71 crore in December

30 Dec 2025 Evaluate

Concord Drugs is currently trading at Rs. 86.00, up by 2.89 points or 3.48% from its previous closing of Rs. 83.11 on the BSE.

The scrip opened at Rs. 80.32 and has touched a high and low of Rs. 86.40 and Rs. 80.32 respectively. So far 18232 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 92.52 on 13-Nov-2025 and a 52 week low of Rs. 26.10 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 88.00 and Rs. 80.20 respectively. The current market cap of the company is Rs. 111.99 crore.

The promoters holding in the company stood at 54.39%, while non-institutions held 45.61% stake in the company.

Concord Drugs has secured purchase orders worth around Rs 14.71 crore from various entities, during the period of December, 2025. The orders are for supply of various pharmaceutical products and to be executed within 45 to 60 days.

Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery.

Concord Drugs Share Price

74.79 2.46 (3.40%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×